about
Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors.Estimation of the regional cerebral metabolic rate of oxygen consumption with proton detected 17O MRI during precision 17O2 inhalation in swine.Mapping of cerebral oxidative metabolism with MRI.Prediction of human pharmacokinetics--gut-wall metabolism.Human biodistribution and radiation dosimetry of 82Rb.Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a reviewA probabilistic model of human variability in physiology for future application to dose reconstruction and QIVIVE.Magnetic Particle Imaging (MPI): Experimental Quantification of Vascular Stenosis Using Stationary Stenosis PhantomsPrediction of human pharmacokinetics - renal metabolic and excretion clearance.Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imagingPrediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.The role of patient-based treatment planning in peptide receptor radionuclide therapy.Development of a physiologically based kinetic model for 99m-technetium-labelled carbon nanoparticles inhaled by humans.Optimal preloading in radioimmunotherapy with anti-cD45 antibody.Setting safe acute exposure limits for halon replacement chemicals using physiologically based pharmacokinetic modeling.Effect of partition coefficient, permeability surface product, and radioisotope on the signal-to-noise ratio in PET functional brain mapping: a computer simulation.Dynamic hysteresis between gradient echo and spin echo attenuations in dynamic susceptibility contrast imaging.Biodistribution and radiation dosimetry of (82)Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging.ORGAN DOSES AND EFFECTIVE DOSE FOR FIVE PET RADIOPHARMACEUTICALS.Effect of contrast material injection duration on arterial enhancement at CT in patients with various cardiac indices: Analysis using computer simulation.
P2860
Q31011083-1951B6A3-253D-4A3B-8775-1F275713EA6DQ33442487-12E48C99-F766-4AF0-AEF1-31B4349299E5Q33977794-FAEAD7B4-1714-46AB-A3FB-FE83C2A9FE64Q34583462-8F2941C3-4729-4EE4-8791-5AEC440EF0C7Q35212024-2BBB63B0-FB4B-4A24-935E-C0959C4073E8Q35556123-B614A441-E98F-47FC-A679-717F0F1CC03BQ36146247-913C0960-0708-4F9F-8878-882E1CCA2ED2Q36240507-FF23B7C0-1095-473C-9002-AF0E175AB29EQ36988426-361A5F1A-99E6-4520-A047-2DB186BC607AQ37126776-E7666EAE-9123-4136-A6F0-1013A128609BQ39805145-871233B1-6CF5-48FD-9C2C-2BAEC90EB5F4Q40311407-E80BE64B-6B16-4055-BDA6-6E928B376C4FQ43488307-6A7863A1-CCD7-4346-99D3-91778C132BC9Q44286280-883A7140-F832-4EEF-90D5-614C539246DDQ47898754-786B50A7-C985-4758-B716-79B03E247A23Q48243110-C2AF9048-B456-4060-AA62-33B5F1CE6CFEQ48501713-13A72A90-AD1E-4823-A64F-8789135D4427Q49126584-60BDDA70-A134-48C7-B2BF-1C2BAD696FADQ51443992-DD4D29F3-6007-4B1F-AF54-413840772660Q55266570-F889ED1E-F201-47C6-9307-DC8A01FAD7D5
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A proposed blood circulation model for Reference Man.
@ast
A proposed blood circulation model for Reference Man.
@en
A proposed blood circulation model for Reference Man.
@nl
type
label
A proposed blood circulation model for Reference Man.
@ast
A proposed blood circulation model for Reference Man.
@en
A proposed blood circulation model for Reference Man.
@nl
prefLabel
A proposed blood circulation model for Reference Man.
@ast
A proposed blood circulation model for Reference Man.
@en
A proposed blood circulation model for Reference Man.
@nl
P1433
P1476
A proposed blood circulation model for Reference Man.
@en
P2093
Leggett RW
Williams LR
P304
P356
10.1097/00004032-199508000-00003
P577
1995-08-01T00:00:00Z